Product information and disease descriptionProduct descriptionProduct information
Pharmacology
21 evidence topics · 9 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionProduct descriptionProduct information
21 evidence topics · 9 sources